Neuronetics, Inc. (NASDAQ:STIM) headquartered in Malvern, will host a conference call for the investment community to discuss the 2Q20 earnings result on 4th August 2020 at 8:30 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.neurostar.com
Earnings Expectation
Neuronetics, Inc. is reporting second quarter financial results on Tuesday 4th August 2020, before market open.
According to analysts surveyed by Thomson Reuters, STIM is expected to report 2Q20 loss of $ 0.51 per share from revenue of $ 8.20 million.
For the full year, analysts anticipate top line of $ 44.37 million, while looking forward to loss of $ 1.87 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 69.00 million ~ $ 71.00 million
Click Here For More Historical Outlooks Of Neuronetics, Inc.
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States, Japan, and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
